Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

AQST holding history

Aquestive Therapeutics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AQST overviewAll 13F holders of AQSTFull Q2 2026 holdings

Shares (Q2 2026)
458,414
Value
$1.91M
% of portfolio
<0.1%
Quarters held
19
Since Q1 2021
Holdings of AQST by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026458,414$1.91M<0.1%−5,793−1.2%ReducedHolders
Q1 2026464,207$1.93M<0.1%+167,762+56.6%AddedHolders
Q4 2025296,445$1.92M<0.1%−202,591−40.6%ReducedHolders
Q3 2025499,036$2.79M<0.1%+137,772+38.1%AddedHolders
Q2 2025361,264$1.20M<0.1%+46,935+14.9%AddedHolders
Q1 2025314,329$911.6K<0.1%−106,234−25.3%ReducedHolders
Q4 2024420,563$1.50M<0.1%+329,874+363.7%AddedHolders
Q3 202490,689$451.6K<0.1%+63,651+235.4%AddedHolders
Q2 202427,038$70.3K<0.1%+25,038+1,251.9%AddedHolders
Q1 20242,000$8.52K<0.1%−290−12.7%ReducedHolders
Q4 20232,290$4.63K<0.1%+2,290NewHolders
Q2 20230$00.0%−3,744−100.0%Sold outHolders
Q1 20233,744$4.27K<0.1%+3,744NewHolders
Q4 20220$00.0%−9,068−100.0%Sold outHolders
Q3 20229,068$11.0K<0.1%+8,653+2,085.1%AddedHolders
Q2 2022415$00.0%−414−49.9%ReducedHolders
Q1 2022829$2.00K<0.1%−1,130−57.7%ReducedHolders
Q4 20211,959$8.00K<0.1%−8,041−80.4%ReducedHolders
Q3 202110,000$44.0K<0.1%−4,060−28.9%ReducedHolders
Q2 202114,060$56.0K<0.1%−114−0.8%ReducedHolders
Q1 202114,174$74.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.